Rural Health
Resources by Topic: Opioids
Rural Health Research Recap: Opioid Use Disorder and Treatment: Rural-Urban Comparisons
Summary of research on opioid use disorder (OUD) among youth, young adults, and pregnant women, the impact of OUD on hospitals and emergency departments, and the use of buprenorphine and partial psychiatric hospitalization programs as treatment for OUD. Features statistics including population-adjusted emergency department rates per 100 people from 2005-2016 and opioid-related emergency room visit rates per 100,000 people in 2006 and 2013, with breakdowns by urban or rural location.
Author(s): Per Ostmo
Date: 02/2022
Sponsoring organization: Rural Health Research Gateway
view details
Summary of research on opioid use disorder (OUD) among youth, young adults, and pregnant women, the impact of OUD on hospitals and emergency departments, and the use of buprenorphine and partial psychiatric hospitalization programs as treatment for OUD. Features statistics including population-adjusted emergency department rates per 100 people from 2005-2016 and opioid-related emergency room visit rates per 100,000 people in 2006 and 2013, with breakdowns by urban or rural location.
Author(s): Per Ostmo
Date: 02/2022
Sponsoring organization: Rural Health Research Gateway
view details
Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties
Highlights a study on the social determinants of health that correlate with high COVID-19 and opioid overdose mortality in rural and urban counties. Breaks down county data by median income, unemployment, and healthcare workforce, among other factors.
Author(s): Yuhui Zhu, Zhe Fei, Larissa J. Mooney, et al.
Citation: Journal of Addiction Medicine, 16(1), e52-e55
Date: 02/2022
view details
Highlights a study on the social determinants of health that correlate with high COVID-19 and opioid overdose mortality in rural and urban counties. Breaks down county data by median income, unemployment, and healthcare workforce, among other factors.
Author(s): Yuhui Zhu, Zhe Fei, Larissa J. Mooney, et al.
Citation: Journal of Addiction Medicine, 16(1), e52-e55
Date: 02/2022
view details
Commission on Combating Synthetic Opioid Trafficking Final Report
Reports on synthetic drug trafficking in the U.S., including the challenges for law enforcement, need for updated drug policy, and surveillance and data analysis concerns. Discusses public health considerations and challenges for reducing the demand for drugs via treatment. Technical Appendixes include rural references throughout, and Figure B.5 shows opioid-involved overdose deaths by Core-Based Statistical Areas (CBSAs) for 2000-2019.
Additional links: Technical Appendixes
Date: 02/2022
Sponsoring organizations: Drug Enforcement Administration, Office of National Drug Control Policy, Office of the Director of National Intelligence, RAND Corporation, U.S. Department of Defense, U.S. Department of Homeland Security, U.S. Department of State, U.S. Department of Treasury, U.S. House of Representatives, U.S. Senate
view details
Reports on synthetic drug trafficking in the U.S., including the challenges for law enforcement, need for updated drug policy, and surveillance and data analysis concerns. Discusses public health considerations and challenges for reducing the demand for drugs via treatment. Technical Appendixes include rural references throughout, and Figure B.5 shows opioid-involved overdose deaths by Core-Based Statistical Areas (CBSAs) for 2000-2019.
Additional links: Technical Appendixes
Date: 02/2022
Sponsoring organizations: Drug Enforcement Administration, Office of National Drug Control Policy, Office of the Director of National Intelligence, RAND Corporation, U.S. Department of Defense, U.S. Department of Homeland Security, U.S. Department of State, U.S. Department of Treasury, U.S. House of Representatives, U.S. Senate
view details
Postmortem Screening of Opioids, Benzodiazepines, and Alcohol among Rural and Urban Suicide Decedents
Presents a study comparing the co-use of opioids and other substances in opioid-related overdose suicides in rural and urban areas. Breaks down 2012-2015 data from the National Violent Death Reporting System (NVDRS) by toxicology reports, sex, and mental health history, among other factors.
Author(s): K.M. Bensley, William C. Kerr, Sarah Beth Barnett, Nina Mulia
Citation: Journal of Rural Health, 38(1), 77-86
Date: 01/2022
view details
Presents a study comparing the co-use of opioids and other substances in opioid-related overdose suicides in rural and urban areas. Breaks down 2012-2015 data from the National Violent Death Reporting System (NVDRS) by toxicology reports, sex, and mental health history, among other factors.
Author(s): K.M. Bensley, William C. Kerr, Sarah Beth Barnett, Nina Mulia
Citation: Journal of Rural Health, 38(1), 77-86
Date: 01/2022
view details
Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices
Examines strategies to improve the treatment of opioid use disorder (OUD) in primary care practices (PCPs) through the program Implementing Technology and Medication Assisted Treatment Team Training in Rural Colorado (IT MATTTRs). Reports on 42 PCPs who participated in IT MATTTRs over 20 months beginning in September 2017. Discusses program efficacy and potential impacts on OUD in rural areas.
Author(s): Linda Zittleman, Kristen Curcija, Donald E. Nease Jr, et al.
Citation: Annals of Family Medicine, 20(1), 18-23
Date: 01/2022
view details
Examines strategies to improve the treatment of opioid use disorder (OUD) in primary care practices (PCPs) through the program Implementing Technology and Medication Assisted Treatment Team Training in Rural Colorado (IT MATTTRs). Reports on 42 PCPs who participated in IT MATTTRs over 20 months beginning in September 2017. Discusses program efficacy and potential impacts on OUD in rural areas.
Author(s): Linda Zittleman, Kristen Curcija, Donald E. Nease Jr, et al.
Citation: Annals of Family Medicine, 20(1), 18-23
Date: 01/2022
view details
Rural and Urban Differences in Undersupply of Buprenorphine Provider Availability in the United States, 2018
Presents a study comparing county-level rates of providers with buprenorphine waivers with rates of opioid-overdose deaths and compares rural and urban areas. Details rural and urban comparisons for 38 states.
Author(s): Kevin P. Conway, Dalia Khoury, Rainer Hilscher, et al.
Citation: Addiction Science and Clinical Practice, 17, 5
Date: 01/2022
view details
Presents a study comparing county-level rates of providers with buprenorphine waivers with rates of opioid-overdose deaths and compares rural and urban areas. Details rural and urban comparisons for 38 states.
Author(s): Kevin P. Conway, Dalia Khoury, Rainer Hilscher, et al.
Citation: Addiction Science and Clinical Practice, 17, 5
Date: 01/2022
view details
Changes in Access to Medication Treatment during COVID-19 Telehealth Expansion and Disparities in Telehealth Use for Medicare Beneficiaries with Opioid Use Disorder
Discusses policies that allow access to medication for opioid use disorder (MOUD) via telehealth before and during the COVID-19 pandemic. Examines outpatient telehealth use and MOUD treatment among Medicare beneficiaries by dual eligibility status, rurality, and presence of comorbid health conditions between April-December 2020.
Date: 01/2022
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Discusses policies that allow access to medication for opioid use disorder (MOUD) via telehealth before and during the COVID-19 pandemic. Examines outpatient telehealth use and MOUD treatment among Medicare beneficiaries by dual eligibility status, rurality, and presence of comorbid health conditions between April-December 2020.
Date: 01/2022
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Outcomes from the Medication Assisted Treatment Pilot Program for Adults with Opioid Use Disorders in Rural Colorado
Examines the efficacy of a medication for opioid use disorder (MOUD) pilot program in two rural Colorado counties. Details the structure and setting of the program, patient characteristics and outcomes, and the limitations of the program.
Author(s): Claudia R. Amura, Tanya R. Sorrell, Mary Weber, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 17(1)
Date: 01/2022
view details
Examines the efficacy of a medication for opioid use disorder (MOUD) pilot program in two rural Colorado counties. Details the structure and setting of the program, patient characteristics and outcomes, and the limitations of the program.
Author(s): Claudia R. Amura, Tanya R. Sorrell, Mary Weber, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 17(1)
Date: 01/2022
view details
Stigma Experienced by Rural Pregnant Women with Substance Use Disorder: A Scoping Review and Qualitative Synthesis
Explores the stigma experienced by rural pregnant women with substance use disorder (SUD). Bases findings on a literature review of studies from 2000-2022. Breaks down the various ways and areas rural pregnant women with SUD experience stigma, such as within the community and healthcare settings. Discusses the importance of comprehensive care that takes these experiences into consideration.
Author(s): Victoria Bright, Julia Riddle, Jean Kerver
Citation: International Journal of Environmental Research and Public Health, 19(22), 15065
Date: 2022
view details
Explores the stigma experienced by rural pregnant women with substance use disorder (SUD). Bases findings on a literature review of studies from 2000-2022. Breaks down the various ways and areas rural pregnant women with SUD experience stigma, such as within the community and healthcare settings. Discusses the importance of comprehensive care that takes these experiences into consideration.
Author(s): Victoria Bright, Julia Riddle, Jean Kerver
Citation: International Journal of Environmental Research and Public Health, 19(22), 15065
Date: 2022
view details
Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop
Offers proceedings from the March 2022 workshop, Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws. Covered topics include personal perspectives on methadone treatment, access and barriers to access for rural and other underserved populations, and federal policies and regulatory flexibilities during the COVID-19 pandemic.
Additional links: Read Online
Author(s): Board on Health Sciences Policy, Board on Health Care Services
Date: 2022
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Offers proceedings from the March 2022 workshop, Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws. Covered topics include personal perspectives on methadone treatment, access and barriers to access for rural and other underserved populations, and federal policies and regulatory flexibilities during the COVID-19 pandemic.
Additional links: Read Online
Author(s): Board on Health Sciences Policy, Board on Health Care Services
Date: 2022
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details